In previous studies, we evaluated the effect of PTX treatment on cervical cancer cells and observed that PTX sensitizes HeLa and SiHa cells to the antitumor effects of CIS by the inhibition of NF-κB (22). This evidence concerns the gene NFKB1 and cervical cancer.